Table 5 Pressure-volume relationship and cardiac work in RV and LV with increased dose of norepinephrine

RV EDV, mL, mean (SD)

186 (30)

151 (18)

0.03

RV ESP, mmHg, median (Q1, Q3)

28 (27, 32)

37 (34, 41)

0.03

RV EDP, mmHg, mean (SD)

13 (2)

11 (3)

0.01

RV Ees, mmHg/mL, median (Q1, Q3)

0.22 (0.18, 0.35)

0.42 (0.35, 0.49)

0.03

RV Ea, mmHg/mL, median (Q1, Q3)

0.52 (0.42, 0.54)

0.67 (0.59, 0.81)

0.09

RV Ea/Ees ratio, median (Q1, Q3)

2.1 (1.7, 2.7)

1.5 (1.3, 2.2)

0.12

LV EDV, mL, mean (SD)

171 (42)

168 (42)

0.90

LV ESP, mmHg, median (Q1, Q3)

60 (57, 64)

85 (84, 88)

0.02

LV EDP, mmHg, mean (SD)

16 (5)

16 (5)

0.77

RV/LV EDV ratio, median (Q1, Q3)

1.14 (0.85, 1.34)

0.87 (0,72, 1.19)

0.12

RV/LV EDP ratio, median (Q1, Q3)

0.91 (0.69, 1.08)

0.73 (0.54, 0.96)

0.11

LV Ees, mmHg/mL, median (Q1, Q3)

0.50 (0.40, 0.62)

0.78 (0.59, 0.87)

0.04

LV Ea, mmHg/mL, median (Q1, Q3)

2.05 (1.49, 3.42)

2.49 (1.84, 3.14)

0.48

LV Ea/Ees, median (Q1, Q3)

4.3 (3.8, 6.2)

3.1 (2.6, 4.7)

0.12

RV SW, mmHg × mL, median (Q1, Q3)

818 (751, 1.065)

1.231 (1.142, 1.335)

0.01

RV PE, mmHg × mL, mean (SD)

1.787 (291)

1.707 (469)

0.63

RV PVA × HR*10³, mmHg/min, mean (SD)

205 (27)

299 (77)

0.003

LV SW mmHg × mL, median (Q1, Q3)

858 (555, 1.392)

2.101 (1.024, 2.613)

0.04

LV PE mmHg × mL, mean (SD)

3.810 (1.105)

4.833 (1.695)

0.28

LV PVA × HR*10³, mean (SD) mmHg/min

363 (89)

687 (235)

0.007